Peter Webborn

Biography

  Dr Peter Webborn has 30 years of experience in the pharmaceutical industry having held a number of senior positions within AstraZeneca, including: Head of DMPK, Drug Safety and Metabolism; Director of Pharmacokinetics and Mass Spectrometry Imaging and DMPK Director of the Centre of Excellence: Discovery/ Early Development. Peter was DMPK lead on AZ’s P2Y12 franchise that yielded Brilinta® (ticagrelor) and Kengreal® (cangrelor). Peter’s expertise in DMPK and his broad experience with both the tactical and strategic running of drug discovery and development projects is highly aligned with our Mironid’s Biology and Medicinal Chemistry teams.

Research Interest

Pharmaceutics, clinical sciences,biotechnology, biomedical, drug delivery, Health Sciences, Sustainability, testing and inspection , chemical, environmental solutions, biochemistry